The eect of a calpain-selective cell permeant inhibitor, benzyloxycarbonyl Leu-Leu-Tyr diazomethylketone (ZLLY-CHN 2 ), on the serum-stimulated growth of WI-38 human ®broblasts has been investigated. Only cell permeant protease inhibitors with activity against calpains prevented progression into S-phase. Protein blotting experiments indicated that p53 immunoreactivity increased in late G 1 cells treated with ZLLY-CHN 2 . The content of p21
Introduction
The calpains are Ca 2+ -requiring proteases which are ubiquitously distributed in cells of multicellular animals (Murachi et al., 1981) . The two major calpain isozymes, m-calpain (calpain I, m-CANP) and m-calpain (calpain II, m-CANP) require approximately 10 75 and 10 73 M Ca 2+ , respectively, for activity in vitro (Saido et al., 1994; Suzuki et al., 1992) . There are other calpain gene family members which are distributed in speci®c tissues (Suzuki et al., 1992) . Calpains have not been found in unicellular organisms, and they have been postulated to have a role in the social regulation of growth of animal cells (Mellgren et al., 1994 . m-Calpain or a closely related protease appears to function in determining the length of G 1 phase in hamster ovary cells . This part of the cell cycle is extensively regulated by a number of control mechanisms designed to ensure that commitment to localized cell division is appropriate within the context of the physiologic state of the organism as a whole (Grana and Reddy, 1995) . Calpain-like proteases appear to participate in the regulation of growth of smooth muscle cells (March et al., 1993) , normal human ®broblasts , and various transformed cells Zhang et al., 1996) . Little is known concerning the speci®c proteins within cells which must be proteolyzed by calpains to exert a proliferative eect. In the present study, we have investigated the in¯uence of calpain inhibitors on growth of serum-stimulated WI-38 human ®broblasts. The results indicate that one cell cycle regulatory target for calpains in these cells is the p53 tumor suppressor gene product.
Results

Inhibition of S-phase progression by benzyloxycarbonyl Leu-Leu-Tyr diazomethylketone (ZLLY-CHN 2 )
WI-38 cells routinely entered S-phase starting at about 16 h after serum stimulation, as revealed by 
. A related cell-permeant inhibitor of cysteine proteases, benzyloxycarbonyl Leu-Val-Tyr diazomethylketone (ZLVG-CHN 2 ), which has little activity against calpains (Mellgren et al., 1994) , was ineective, even at 20 mM.
Eect of ZLLY-CHN 2 on early G 1 events
Previous investigations have suggested the possibility that calpain-like proteases might in¯uence the expression or turnover of immediate early gene products (March et al., 1993; Hirai et al., 1991) . A study was therefore undertaken to investigate the expression of c-Jun and cFos in WI-38 cells exposed to ZLLY-CHN 2 . Cyclin D 1 , the expression of which is induced following dimerization of c-Fos and c-Jun into AP-1 transcription factor, was also investigated as a potential calpain substrate. Overall, ZLLY-CHN 2 had very little in¯uence on the levels of any of these three proteins (Figure 3 ). The only consistent eect, observed in three independent experiments, was a modest increase in c-Jun immunoreactivity 3 and 5 h after serum addition in the presence of ZLLY-CHN 2 (Figure 3 , top panel). ZLVG-CHN 2 did not consistently alter the disappearance of c-Jun at these time points relative to the DMSO control. All samples showed a second peak of c-Jun protein expression at the beginning of S-phase; a phenomenon which has been noted before in WI-38 ®broblasts (Carter et al., 1991) . ZLLY-CHN 2 appeared to have no eect on the generation of this second peak (Figure 3 ) or on c-Jun stability in S-phase (data not shown).
Eect of calpain inhibitors on late G 1 events
Because ZLLY-CHN 2 unexpectedly had little eect on the levels of c-Jun and c-Fos protein in early G 1 and on subsequent induction of cyclin D, we conducted a thorough time course of its eect on progression through the entire G 1 to S-phase transition. This study indicated that ZLLY-CHN 2 could be removed from the culture medium up to 12 h after serum addition, with little eect on the subsequent entry of the cells into S-phase (Figure 4 , ®lled bars). Moreover, addition of ZLLY-CHN 2 at various times after serum stimulation produced inhibition up until most of the cells had entered S-phase (Figure 4 , open bars). Thus, this inhibitor appeared to block a late G 1 event. Of several other protease inhibitors added to serumstimulated WI-38 cells at late G 1 , only those with activity against calpain were potent inhibitors of Sphase progression (Table 1) .
p53 as a target for ZLLY-CHN 2
Because the tumor suppressor p53 is known to be a regulator of entry into S-phase, the eect of ZLLY-CHN 2 administration on the content of this protein in serum-stimulated WI-38 cells was studied. The results demonstrated an accumulation of p53 at late G 1 and early S-phase in cells exposed to this inhibitor ( Figure 5 , lower panel). Dose-response studies showed that halfmaximum increase in p53 protein occurred in cells treated with 4 mM ZLLY-CHN 2 ( Figure 6 ); approximately the same concentration which produced 50% inhibition of [ At indicated times, cells were washed, suspended in lysis buer and subjected to protein immunoblotting as described in the methods section p53 proteolysis by a calpain-like protease W Zhang et al of p53 (not shown). In contrast, ZLVG-CHN 2 did not increase p53 content at concentrations as high as 50 mM ( Figure 6 ). The p53 accumulated after exposure of WI-38 cells to ZLLY-CHN 2 appeared to be capable of transactivating gene targets, since p21 Waf1/Cip1 was expressed at increased levels near S-phase ( Figure 7 ). The increased content of this inhibitor of G 1 CDK-cyclin complexes (El-Deiry et al., 1993; Harper et al., 1993) provides a molecular mechanism for the failure of the WI-38 cells to enter S-phase following exposure to ZLLY-CHN 2 . If ZLLY-CHN 2 protects p53 from degradation by a calpain-like protease and allows arrest at late G 1 , then removal of this inhibitor should allow p53 degradation and progression into S-phase. Previous experiments had shown that WI-38 cells entered S-phase following removal of ZLLY-CHN 2 at 12 h after serum-stimulation (Figure 4) . Removal of ZLLY-CHN 2 at this time also permitted p53 degradation over the following 8 h (Figure 8a ). The loss of p53 immunoreactivity was most pronounced over the last 4 h of recovery from the eects of ZLLY-CHN 2 (Figure 8a, lane 8) . In contrast, when cells were allowed to progress 18 h after serum stimulation in the presence of ZLLY-CHN 2 , subsequent removal of the inhibitor did not result in marked degradation of p53 over the next 8 h (Figure 8b ). Thus, there appears to be a`window' for p53 degradation between 12 and 18 h after serum-stimulation.
It was possible that ZLLY-CHN 2 increased p53 content by inducing increased expression of p53. To investigate this possibility, p53 mRNA content in WI-38 cells was studied by Northern blot analysis following serum stimulation plus or minus ZLLY-CHN 2 . Exposure WI-38 cells were serum-stimulated in the presence of various concentrations or ZLLY-CHN 2 (lanes 1 ± 6) or ZLVG-CHN 2 (lanes 7 ± 12). After 24 h, cell lysates were immunoblotted for p53 as described in the methods section. Lanes 1 and 7=no inhibitor; lanes 2 and 8=4 mM inhibitor; lanes 3 and 9=6 mM inhibitor; lanes 4 and 10=10 mM inhibitor; lanes 5 and 11=20 mM inhibitor; lanes 6 and 12=50 mM inhibitor. S=protein standards These results indicate that the eects of ZLLY-CHN 2 are mediated through inhibition of a calpain-like protease necessary for removal of constitutively expressed p53 at or near the G 1 /S boundary, rather than through increasing the expression of p53.
Accumulation of m-calpain in WI-38 nuclei in late G 1 -phase p53 functions as a regulator of G 1 to S-phase transition at least in part by acting as a transcription factor. If calpains are required to prevent progression into Sphase, then it is likely that they would proteolyze nuclear p53. Immuno¯uorescence microscopy studies indicated an accumulation of m-calpain in cell nuclei in late G 1 , speci®cally at 16 h after serum-stimulation. At 14 and 20 h after serum addition, weak m-calpain immunoreactivity was distributed throughout the cell, and was not discernible above the control immunouorescence. A representative experiment is depicted in Figure 10 . The sudden appearance of m-calpain immunostaining in nuclei was not the result of an increase in its biosynthesis at this time, since protein immunoblot studies did not reveal an increase in mcalpain protein (data not shown). Thus, the timing of nuclear accumulation of m-calpain is similar to the critical period for the inhibition of S-phase progression and p53 degradation by ZLLY-CHN 2 .
Eect of EGTA on p53 degradation
If a calpain-like activity is required for p53 degradation in late G 1 , then it is possible that it is activated by an increase in intracellular Ca 2+ at this time. There is evidence for a transient elevation in intracellular Ca 2+ immediately prior to induction of S-phase in WI-38 ®broblasts (Wahl and Gruenstein, 1993) . Cells were serum-stimulated in the presence of ZLLY-CHN 2 for 12 h and then cultured without ZLLY-CHN 2 and with 40 mM cycloheximide. The Ca 2+ present in the DMEM medium used in our studies (approximately 2.2 mM) was titrated by addition of increasing concentrations of EGTA to the culture¯asks. After 8 h, cell extracts were prepared and immunoblotted for p53. At approximately equimolar concentrations of EGTA and Ca 2+ , loss of p53 immunoreactivity following removal of ZLLY-CHN 2 was partially prevented (Figure 11 ). At EGTA concentrations of 2.5 mM or greater, maximum prevention of decrease was noted. These results indicate that extracellular Ca 2+ was important for loss of p53, but relatively low Ca 2+ concentrations in the medium were capable of supporting p53 degradation.
Degradation of p53 by puri®ed m-calpain
The p53 present in WI-38 cell extracts was incubated with puri®ed human m-calpain and various Ca 2+ concentrations as described in the Materials and methods section. Signi®cant proteolysis of p53 was evident at 1 mM Ca 2+ (Figure 12a ), and nearly complete proteolysis was obtained in the presence of 3 mM Ca
2+
. Similar experiments with puri®ed m-calpain showed that it required Ca 2+ concentrations greater than 0.5 mM to produce proteolysis (Figure 12b) . No p53 immunoreactive breakdown products were detected upon cleavage with either calpain isozyme. Treatment of WI-38 cells with ZLLY-CHN 2 does not increase p53 mRNA levels. Serum-deprived WI-38 cells were stimulated with serum-containing medium, and 10 h later, 10 mM ZLLY-CHN 2 (lanes 6 ± 9) or an equivalent volume of DMSO (lanes 2 ± 5) were added. At 0 h (lanes 2 and 6), 2 h (lanes 3 and 7), 3.5 h (lanes 4 and 8), or 5 h (lanes 5 and 9) later, cell lysates were subjected to Northern blot analysis for p53 mRNA (a). Lane 1=serum-starved cells. The blot was then stripped, and re-probed for glyceraldehyde-3-phosphate dehydrogenase mRNA (b)
Discussion
Calpain inhibitors block progression to S-phase
While it is now well established that regulated proteolysis of cell cycle proteins is crucial for orderly progression of the cycle (Minshull et al., 1989; Murray, 1989; Glotzer et al., 1991; Liao et al., 1995; Hsu et al., 1996) , few studies have addressed the role of the well known and ubiquitous Ca 2+ -dependent proteases, calpains, in this process. It was previously demonstrated that thiol protease inhibitors like ALLN-CHO could inhibit the proliferative growth of vascular smooth muscle cells at G 1 and G 2 /M-phases (March et al., 1993) . In the present study, we have shown that cell permeant peptide inhibitors of calpains are potent inhibitors of the G 1 to S-phase transition in normal human WI-38 ®broblasts (Table  1) . In contrast, a number of other cell permeant inhibitors were not particularly eective in this respect. The observed inhibition of traverse through G 1 does not, of course, address the possible involvement of calpain-like activities in regulation of other cell cycle phases.
Of prime importance is the lack of eect of ZLVG-CHN 2 and benzyloxycarbonyl Phe-Ala diazomethylketone (ZFA-CHN 2 ) on G 1 progression: ZLLY-CHN 2 is a potent irreversible inhibitor with substantial specificity for calpains and cathepsin L (Crawford et al., 1988; Anagli et al., 1993) , and the aformentioned peptidyl diazomethyl ketones inhibit cathepsin L, but Figure 11 The eect of extracellular EGTA on proteolysis of p53. Cells were treated with serum and 20 mM ZLLY-CHN 2 for 12 h and changed to medium minus inhibitor and plus cycloheximide as described in the Materials and methods section. The latter medium was supplemented with dierent concentrations of EGTA as indicated, and p53 content in the cells was assessed 8 h after changing medium p53 proteolysis by a calpain-like protease W Zhang et al not calpains (Crawford et al., 1988; Mellgren et al., 1993) . Thus, the anti-proliferative eect of ZLLY-CHN 2 cannot be attributed to its inhibition of a cathepsin L-like activity. Also worth noting is the relative ineectiveness of benzyloxycarbonyl Val-Ala-Asp¯uoromethylketone (ZVAD-CH 2 F) as an antiproliferative agent. The latter is an inhibitor of interleukin-1b converting enzyme (ICE)-like proteases which are important mediators of apoptosis (Earnshaw, 1995) . In other studies, we have found that 100 mM ZVAD-CH 2 F can fully inhibit cycloheximide-induced apoptosis of HL-60 promyelocytic leukemia cells . In contrast, this concentration of ZVAD-CH 2 F produced less than 50% inhibition of [ 3 H]thymidine incorporation in WI-38 cells, compared with the essentially total inhibition produced by calpainspeci®c inhibitors. The modest inhibition observed could well be explained by the ability of ZVAD-CH 2 F to inhibit calpain at the concentration used in these studies: half-maximum inhibition of puri®ed human mcalpain is observed at about 10 mM ZVAD-CH 2 F under standard assay conditions (Zhang and Mellgren, unpublished data) .
Finally, the experiments reported in the present study taken together with the results of previous studies makes it highly unlikely that the ATPubiquitin-dependent proteolytic system is the direct target for ZLLY-CHN 2 . ALLN-CHO and ZLLY-CHN 2 are capable of inhibiting the proteasome catalytic component of the ATP-ubiquitin-dependent proteolytic system, but only at much higher concentrations than required to inhibit calpains (Orlowski et al., 1993; Mellgren et al., 1994) . The inhibition of WI-38 cell cycle progression by 5 mM ZLLY-CHN 2 or less (Figure 2) is inconsistent with the observation that the caseinolytic activity of puri®ed human erythrocyte proteasome is inhibited less than 50% by 50 mM ZLLY-CHN 2 (Mellgren et al., 1994) . Other observations also argue against the proteasome as a target for ZLLY-CHN 2 . Accumulation of ubiquitinylated forms of p53 were not detected in cells treated with ZLLY-CHN 2 (e.g. Figure 6a ). Previous studies have shown that the growth of S cerevisiae is not inhibited by 50 mM ZLLY-CHN 2 (Mellgren et al., 1994) , even though it possesses close homologs of many of the cell cycle regulatory proteins found in higher organisms, including the proteasome (Hershko, 1991) . There has been no report of a yeast homolog of calpains.
Degradation of p53 in late G 1
The accumulation of p53 in WI-38 cells during G 1 was increased upon their exposure to ZLLY-CHN 2 , and this was accompanied by an increased expression of p21
Waf1
. These observations provide a mechanism for the inhibition of progression into S-phase produced by this calpain inhibitor. The increased p53 content could have been the result of increased expression of the p53 gene. However, it was found that p53 mRNA content of WI-38 cells was not in¯uenced by the presence of ZLLY-CHN 2 in the culture medium (Figure 9) . p53 protein appears to be stabilized and cell cycle progression is thereby halted, when cells are exposed to general toxic conditions which produce DNA damage (Maltzman and Czyzk, 1984; Kouzarides, 1995) . This does not appear to be a likely explanation for the G 1 -phase arrest produced by ZLLY-CHN 2 and the other calpain inhibitors, since there is clearly a speci®city related to their abilities to inhibit calpains (Table 1, Figure 6 ). Moreover, the relatively fast recovery of entry into S-phase upon removal of ZLLY-CHN 2 from culture medium (Figure 4) argues against the delayed type of toxicity associated with DNA damage and subsequent repair after removal of the DNA damaging agent. In WI-38 ®broblasts, recovery of growth is delayed for over 2 days after damage of only one or two DNA sites by ionizing radiation (Di Leonardo et al., 1994) . The absence of an in¯uence on growth of S cerevisiae (Mellgren et al., 1994) is also incompatible with a general toxic eect of ZLLY-CHN 2 . Finally, ZLLY-CHN 2 and the other drugs used in our studies did not produce acute toxicity as determined by trypan blue dye exclusion.
The experiments reported in the present work indicate that a calpain-like activity is responsible for Figure 12 Proteolysis of p53 by puri®ed calpains. WI-38 cell lysates were incubated with puri®ed human erythrocyte m-calpain (a) or puri®ed bovine myocardial m-calpain (b) and the indicated Ca 2+ concentration as described in the Materials and methods section. Samples were subjected to gel electrophoresis and immunoblot analysis utilizing the UBI (a) or DO-1 (b) p53 antibodies. The asterisk indicates non-speci®c staining of a calpain large subunit fragment produced by autoproteolysis, note that it appears only after nearly complete loss of p53 immunostaining p53 proteolysis by a calpain-like protease W Zhang et al the degradation of p53 observed in late G 1 : p53 content accumulated only in the presence of calpain inhibitors, p53 degradation appeared to require extracellular Ca 2+ , m-calpain was transported to the cell nucleus at the critical time for p53 degradation and p53 was proteolyzed by puri®ed m-calpain at Ca 2+ concentrations as low as 1 mM. While these experiments suggest that m-calpain or a related novel calpain may be responsible for p53 proteolysis in late G 1 , they do not rule out a role for m-calpain, and more extensive investigation will be required to specify the calpain isozyme(s) involved.
It is noteworthy that cleavage with puri®ed calpains did not result in lower molecular weight immunoreactive p53 fragments (Figure 12 ). Calpains usually produce limited proteolysis, resulting in the accumulation of protein fragments which can be observed on polyacrylamide gels (Takahashi, 1990) . The absence of such fragments had been recognized early on in the cell culture studies and chloroquine was added to culture medium in some experiments to inhibit lysosomal proteolysis, in attempts to inhibit further degradation of p53. However, addition of this lysosomotropic agent in experiments similar to those shown in Figure 8 did not result in accumulation of p53 fragments (not shown). The loss of the native p53 band was observed, con®rming the lack of in¯uence of lysosomal proteases on p53 degradation in late G 1 . In other experiments, 2-deoxyglucose and dinitrophenol were added to cell culture medium 8 h before preparing cell lysates, to deplete ATP. No low molecular weight p53 fragments were observed when these lysates were incubated with m-calpain and 0.3 to 10 mM Ca 2+ (not shown). Thus, conditions which inactivate ATP-ubiquitin dependent proteolysis did not spare putative limit peptides produced by calpain-catalyzed cleavage. The calpains may cleave p53 at or near the epitopes of the DO-1 and UBI antibodies, destroying the epitopes, or producing small immunoreactive fragments which cannot be detected by immunoblotting.
A model for p53 proteolysis and G 1 progression Figure 13 depicts the model for p53 proteolysis in late G 1 which we believe best ®ts the experimental results discussed above. Upon stimulation with mitogens, quiescent WI-38 ®broblasts express p53, and its content increases as the cells go through G 1 . This is consistent with our studies (Figure 5a ) and has been previously noted by others (Shaulsky et al., 1990; Katsumoto et al., 1995) . At a critical point near the end of G 1 , p53 is targeted for destruction by a calpain-like protease. Initial studies suggest that the signal requires extracellular Ca 2+ (Figure 11 ). Abrogation of this signal is accompanied by accumulation of p53 and of p21 Waf1 resulting in G 1 arrest. This model implies that the status of the calcium-dependent proteolytic system in multicellular animals has a potential role in regulating the G 1 to S-phase transition.
While the present studies have focused on the proteolysis of p53 by calpains, it is likely that other cell cycle regulators, acting during G 1 or at other phases of the cell cycle (March et al., 1993) , are also substrates for calpain-like enzymes. Preliminary studies carried out in the investigators' laboratory indicate that several dierent cell lines in which p53 function is lost by mutation or sequestration are also sensitive to inhibition by the calpain inhibitors. It will be important to identify other G 1 -phase targets for calpains, and to delineate the signal transduction pathways which lead to degradation of p53 and the other calpain substrates.
Materials and methods
Materials
Anti-c-Jun polyclonal Ab and anti-p21(Waf1/Cip1) monoclonal Ab were from Oncogene Sci, Inc. Anti-c-Fos polyclonal Ab was from Santa Cruz Biotech, Inc. Anticyclin D polyclonal Ab and clone Bp53-12 anti-p53 monoclonal Ab were obtained from UBI. DO-1 anti-p53 monoclonal Ab and p53 cDNA probe were purchased from Oncogene Science, Inc. Glyceraldehyde-3-phosphate dehydrogenase reference probe was kindly supplied by Dr T Chiu, Department of Pharmacology. ZLLY-CHN 2 and ZVAD-CH 2 F were obtained from Enzyme System Products. ALLN-CHO was obtained from Boehringer Mannheim. ZFA-CHN 2 was a kind gift from Dr Elliott Shaw, Friedrich Miescher Institut, Basel. Other protease inhibitors used in these studies were obtained from Sigma. mCalpain and m-calpain were puri®ed to near homogeneity from human erythrocytes and bovine heart, respectively, as previously described (Mellgren, 1991) .
Methods
Cell culture WI-38 normal diploid human ®broblasts, obtained from American Type Culture Collection, were routinely cultured as monolayers at 378C and 5% CO 2 , in DMEM containing 10% FBS. The cell cultures were used for experiments between passages 20 and 30. For serum stimulation studies, the cells were grown to approximately 60% to 80% con¯uence and then serum was omitted from culture medium. After 3 days, when most of the cells were quiescent as determined by loss of [ 3 H]thymidine incorporation, 10% FBS was added to the medium, plus or minus other additions as indicated, to stimulate cell growth. Prior to the preparation of cell extracts for analysis, cell viability was assessed in representative culture wells by trypan blue dye exclusion. Under the conditions employed in the experiments described, protease Figure 13 Model for p53 proteolysis in late G 1 -phase. Serum stimulation of quiescent WI-38 ®broblasts induces p53 expression. At a critical time in late G 1 , p53 breakdown by a calpain-like protease is necessary to prevent G 1 arrest (solid line). In the presence of calpain inhibitors (dashed line), p53 is not degraded, and p21 is expressed, preventing entry into S-phase p53 proteolysis by a calpain-like protease W Zhang et al inhibitors, cycloheximide and EGTA did not produce signi®cant acute toxicity: viability was always between 95% and 99%.
[ 3 H]thymidine incorporation WI-38 cells were cultured in 12 well plates at 80% con¯uency. Cells were serum-stimulated as described above, and protease inhibitors were added at the indicated times. At various times 0.5 to 2 mCi of [ 3 H]-thymidine was added to the culture medium, and the cells were labeled for 1 h. The cells were lysed, and 3 H-labeled DNA was extracted as previously described (Freshney, 1987) and counted in a liquid scintillation counter.
Electrophoresis and protein immunoblotting Cells were cultured in 35 mm dishes. Before lysis, culture dishes were washed twice with PBS, then 0.4 ml of SDS ± PAGE sample buer was added to lyse the cells. Cell lysates were heated at 1008C for 5 min, and applied to 10% polyacrylamide gels. Western blotting was done by standard procedures using an alkaline phosphatase-conjugated second antibody (Blake et al., 1984) .
Northern blotting Cells were cultured in 100 mm dishes. Total RNA was extracted by TRI REAGENT according to the manufacturer's instructions. RNAs were separated on a 1% formaldehyde agarose gel. The RNAs were transferred to a nylon ®lter and crosslinked with u.v. light. The ®lter was hybridized to 32 P-labeled probe at 428C for 17 h in 50% formamide, 56 Denhardt's solution, 26 SSC, 0.1% SDS, 1 mM EDTA, containing 0.2 mg sheared salmon sperm DNA/ml. The ®lter was washed twice in 26 SSC/ 0.1% SDS for 15 min at room temp, and then twice in 0.26 SCC/0.1% SDS for 15 min at 658C. The ®lter was autoradiographed.
Degradation of p53 in late G 1 -phase WI-38 cells were serum-stimulated in the presence of 10 mM ZLLY-CHN 2 , and medium was removed after 12 h. DMEM containing 10% FBS, 40 mM cycloheximide, and any other additions was added. At indicated times, cell lysates were immunoblotted for p53, usually employing the UBI antip53 monoclonal antibody as the ®rst antibody. Occasionally DO-1 antibody was utilized. No consistent dierence was observed in results obtained with these two ®rst antibodies.
Immuno¯uorescent microscopic localization of m-calpain in WI-38 cells Quiescent WI-38 cells were serum-stimulated, and ®xed at various times thereafter for immunolocalization of m-calpain as previously described (Lane et al., 1992) . The primary antibody utilized was the P-6 monoclonal antibody prepared against human erythrocyte m-calpain (Lane et al., 1992) . Western blot analysis demonstrated that it only recognized m-calpain large subunit in SDS-solubilized WI-38 cells (not shown).
In vitro digestion of p53 with puri®ed calpains WI-38 cells in a 75 cm 2¯a sk were serum-stimulated for 24 h in the presence of 20 mM ZLLY-CHN 2 . The cells were washed four times with PBS and scraped in 1.0 ml of lysis buer: 100 mM imidazole-HCl, 2 mM HEDTA, 2 mM DTT, 0.1 mM PMSF, 10 mM PMSF, 10 mM pepstatin A and 0.1% Triton X-100, pH 7.0. The lysed cells were centrifuged at 10 000 g for 10 min. Seventy microliters of supernatants were incubated with 20 mg/ml m-calpain or mcalpain at 258C, and CaCl 2 was added from a stock solution to give the desired free Ca 2+ concentration (Mellgren, 1991) . Control experiments veri®ed that addition of CaCl 2 to the lysis buer over the range used in these studies did not measurably alter buer pH. After 10 min, SDS-sample buer was added, the samples were processed for gel electrophoresis and blotting and p53 was detected by immunoblot analysis using the UBI or DO-1 antibody.
